ArticleJournal for immunotherapy of cancer2020

Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer.

Eva Crespo-Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.